A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.

The Journal of Experimental Medicine
Jeremy WarshauerMark Anderson

Abstract

Naturally occurring cases of monogenic type 1 diabetes (T1D) help establish direct mechanisms driving this complex autoimmune disease. A recently identified de novo germline gain-of-function (GOF) mutation in the transcriptional regulator STAT3 was found to cause neonatal T1D. We engineered a novel knock-in mouse incorporating this highly diabetogenic human STAT3 mutation (K392R) and found that these mice recapitulated the human autoimmune diabetes phenotype. Paired single-cell TCR and RNA sequencing revealed that STAT3-GOF drives proliferation and clonal expansion of effector CD8+ cells that resist terminal exhaustion. Single-cell ATAC-seq showed that these effector T cells are epigenetically distinct and have differential chromatin architecture induced by STAT3-GOF. Analysis of islet TCR clonotypes revealed a CD8+ cell reacting against known antigen IGRP, and STAT3-GOF in an IGRP-reactive TCR transgenic model demonstrated that STAT3-GOF intrinsic to CD8+ cells is sufficient to accelerate diabetes onset. Altogether, these findings reveal a diabetogenic CD8+ T cell response that is restrained in the presence of normal STAT3 activity and drives diabetes pathogenesis.

References

Dec 31, 1997·The Journal of Experimental Medicine·J VerdaguerP Santamaria
Jul 9, 2003·The Journal of Experimental Medicine·Mohammed Javeed I AnsariMohamed H Sayegh
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Jun 9, 2004·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Jun 15, 2004·Biochemical and Biophysical Research Communications·Shin-Ichi GorogawaMasatsugu Hori
Apr 12, 2006·The Journal of Experimental Medicine·Mary E KeirArlene H Sharpe
Feb 9, 2010·Nature Immunology·Brian D StadinskiKathryn Haskins
Sep 3, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ashish K MarwahaRusung Tan
Oct 20, 2012·Nature Reviews. Immunology·Susan M Kaech, Weiguo Cui
Mar 21, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Rachel FinckSean C Bendall
Jul 21, 2014·Nature Genetics·Sarah E FlanaganAndrew T Hattersley
Jan 23, 2016·Methods in Molecular Biology·Evy De Leenheer, F Susan Wong
Mar 8, 2016·Journal of Autoimmunity·Jane H Buckner, Gerald T Nepom
Jul 6, 2016·Frontiers in Immunology·Patrick MaffucciCharlotte Cunningham-Rundles
May 6, 2017·Nature Medicine·Carl H JuneJeffrey A Bluestone
Nov 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Thomas CiucciRémy Bosselut
Dec 7, 2017·Nature·J Justin MilnerAnanda W Goldrath
Jun 1, 2018·The Journal of Clinical Investigation·Lorraine YeoMark Peakman
Jul 15, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emmi-Leena IhantolaTuure Kinnunen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.